T-cell dysfunction in hairy cell leukemia: An updated review

Leukemia and Lymphoma

Volumn 30, Issue 1-2, 1998, Pages 31-39

  Van De Corput, L ^a   Falkenburg, J H F ^a   Kluin Nelemans, J C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hairy cell leukemia; Human spleen; Lack of CD28; Monocytopenia; Restricted TCRBV expression; T cell dysfunction

Indexed keywords

CD28 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN PRESENTATION; CELL FUNCTION; CYTOPENIA; HAIRY CELL LEUKEMIA; HUMAN; MONOCYTE; PRIORITY JOURNAL; REVIEW; SPLEEN; T LYMPHOCYTE;

EID: 0031843762     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809050927     Document Type: Review

References (77)

1. Cawley, J. C., Burns, G. F. and Hayhoe, F. G. J. (1980). Hairy cell leukemia. (Springer Verlag, Berlin) pp. 85-86.
2. Wu, S. H., Vendantham, S., Rosner, M. C., Lovis, R. M., Golomb, H. M. and Gamliel, H. (1992). Ultrastructural characteristics of the spleen in hairy cell leukemia. Leukemia and Lymphoma, 8, 137-142.
3. Knight, R. A., Worman, C. P. and Cawley, J. C. (1983). Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukaemia. Clinical Experimental Immunology, 53, 600-604.
4. Ruco, L. P., Procopio, A., Maccalini. V., Calogero, A., Uccini, S., Annino, L., Mandelli, F. and Baroni, C. D. (1983). Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood, 61, 1132-1137.
5. Trentin, L., Zambello, R., Agostini, C., Ambrosetti, A., Chisesi, T., Raimondi, R., Bulian, P., Pizzolo, G. and Semenzato, G. (1990). Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood, 75, 1525-1530.
6. Demete, J. and Benczur, M. (1989). Hairy cells are not lysed by autologous LAK cells. Blut, 58, 49-50.
7. Quesada, J. R., Hersh, E. M., Manning, J., Reuben, J., Keating, M., Schnipper, E., Itri, L. and Gutterman, J. U. (1986). Treatment of hairy cell leukemia with recombinant α-interferon. Blood, 68, 493-497.
8. Golomb, H. M., Jacobs, A., Fefer, A., Ozer, H., Thompson, J., Portlock, C., Rarain, M., Golde, D., Vardiman, J., Burke, J. S., Brady, J., Bonnem, E. and Spiegel, R. (1986). Alpha-2-interferon therapy of hairy cell leukemia: a multicenter study of 64 patients. Journal of Clinical Oncology, 4, 900-905.
9. Lauria, F., Foa, R., Raspadori, D., Zinzani, P. L., Buzzi, M., Fierro, M. T., Bonferroni, M., Fanin, R., Gallizia, C., Michieli, M. G., Degani, G., Resegotti, L. and Tura, S. (1988). Treatment of hairy-cell leukaemia with α-interferon (α-IFN). European Journal of Cancer and Clinical Oncology, 24, 195-200.
10. Jaiyesimi, I. A., Kantarjian, H. M. and Estey, E. H. (1993). Advances in therapy for hairy cell leukemia. Cancer, 72, 5-15.
11. +) in hairy cell leukemia. Leukemia, 7, 46-50.
12. Romagnani, S. (1994). Lymphokine production by human T-cells in disease status. Annual Review of Immunology, 12, 227-257.
13. Janckila, A. J., Wallace, J. H. and Yam, L. T. (1982). Generalized monocyte deficiency in leukaemic reticuloendotheliosis. Scandinavian Journal of Haematology, 29, 153-160.
14. Worman, C. P. and Cawley, J. C. (1982). Monoclonal antibody-defined T-cell subsets in hairy cell leukaemia. Scandinavian Journal of Haematology, 29, 338-344.
15. Ford, R. J., Mehta, S. and Sharma, S. (1987). In vitro studies on leukemic cells and T-lymphocytes in hairy cell leukemia. Leukemia, 1, 386-389.
16. + cells expressing Vγ9Vδ2, which normally predominate the blood, are found in the spleens of patients with hairy cell leukemia. Leukemia, 11, 106-109.
17. Gasché, C., Reinisch, W. and Schwarzmeier, J. D. (1993). Evidence of colony suppressor activity and deficiency of hematopoietic growth factors in hairy cell leukemia. Hematological Oncology, 11, 97-104.
18. Briggs, P. G., Kraft, N. and Atkins, R. C. (1990). T-cells and CD45R expression in B-chronic lymphocytic leukemia. Leukemia Research, 14, 155-159.
19. Pinto, L., Covas, M. J. and Victorino, R. M. M. (1991). Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients. Immunology, 73, 147-150.
20. +), and T cytotoxic (CD8*CDllb~) subsets in human immunodeficiency virus infection. Journal of Clinical and Laboratory Analysis, 5, 96-100.
21. Miedema, F., Meyaard, L., Koot, M., Klein, M. R., Roos, M. T. L., Groenink, M., Fouchier, R. A. M., Van't Wout, A. B., Tersmette, M., Schellekens, P. T. A. and Schuitemaker, H. (1994). Changing virus-host interactions in the course of HIV-1 infection. Immunological Reviews, 140, 35-72.
22. Kluin-Nelemans, J. C., Kester, M. G. D., Oving, I., Cluitmans, F. H. M., Willemze, R. and Falkenburg, J. H. F. (1994). Abnormally activated T-lymphocytes in the spleen of patients with hairy cell leukemia. Leukemia, 8, 2095-2101.
23. Schwartzentruber, D. J., Stetler-Stevenson, M., Rosenberg, S. A. and Topalian, S. L. (1993). Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-α in response to autologous tumor stimulation. Blood, 82, 1204-1211.
24. Lindemann, A., Ludwig, W. D., Oster, W., Mertelsmann, R. and Hermann, F. (1989). High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood, 73, 880-884.
25. Cordingly, F. T., Hoffbrand, A. V., Heslop, H. E., Turner, M., Blanchi, A., Reittie, J. E., Vyakarnam, A., Meager, A. and Brenner, M. K. (1988). Tumor necrosis factor as an autocrine tumor growth factor for chronic B-cell malignancies. Lancet, 1, 969-971.
26. Buck, C., Digel, W., Schoniger, W., Stefanie, M., Raghavachar, A. and Porzsolt, F. (1988). Tumor necrosis factor and hairy cell leukemia. Lancet, 2, 402-406.
27. - T-cells in hairy cell leukemia (HCL). Keystone, Cellular Immunology and the Immunotherapy of Cancer-III, Copper Mountain, Abstract.
28. Azuma, M., Cayabyab, M., Buck, D., Philips, J. H. and Lanier, L. L. (1992). CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T-lymphocytes. Journal of Experimental Medicine, 175, 353-360.
29. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K. and Ledbetter, J. A. (1991). Binding of the B-cell activation antigen B7 to CD28 costimulates T-cell proliferation and interleukin 2 mRNA accumulation. Journal of Experimental Medicine, 173, 721-730.
30. Rossi, E., Matutes, E., Morilla, R., Owusu-Ankomah, K., Heffernan, A. M. and Catovsky, D. (1996). Zeta chain and CD28 are poorly expressed on T-lymphocytes from chronic lymphocytic leukemia. Leukemia, 10, 494-497.
31. Holland, G. and Zlotnik, A. (1993). Interleukin-10 and cancer. Cancer Investigations, 11, 751-758.
32. Blay, J-Y., Burdin, N., Rousset, F., Lenoir, G., Biron, P., Philip, T., Banchereau, J. and Favrot, M. C. (1993). Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood, 82, 2169-2174.
33. Cortes, J. E., Talpaz, M., Cabanillas, F., Seymour, J. F. and Kurzrock, R. (1995). Serum levels of interleukin-10 in patients with diffuse large cell lymphomas: Lack of correlation with prognosis. Blood, 85, 2516-2520.
34. + T-cell clones and resting T-cells. Journal of Immunology, 150, 4754-4765.
35. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W. and O'Garra, A. (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology, 146, 3444-3451.
36. Schlaak, J. F., Hermann, E., Gallati, H., Meyer zum Buschfelde, K. H. and Fleischer, B. (1994). Differential effects of IL-10 on proliferation and cytokine production of human γ/δ and α/β T-cells. Scandinavian Journal of Immunology, 39, 209-215.
37. Jansen, J. H., Wientjes, G. J. H. M., Willemze, R. and Kluin-Nelemans, J. C. (1992). Production of tumor necrosis factor-α by normal and malignant B-lymphocytes in response to interferon-α. interferon-γ and interleukin-4. Leukemia, 6, 116-119.
38. Steis, R. G., Marcon, L., Clark, J., Urba, W., Longo, D. L., Nelson, D. L. and Maluish, A. E. (1988). Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia. Blood, 71, 1304-1309.
39. Semenzato, G., Foa, R., Agostini, C., Zambello, R., Trentin, L., Vinante, F., Benedetti, F., Chilosi, M. and Pizzolo, G. (1987). High serum levels of soluble interleukin-2 receptor in patients with B chronic lymphocytic leukemia. Blood, 70, 396-400.
40. Digel, W., Porzsolt, F., Schmid, M., Hermann, F., Lesslauer, W. and Brockhaus, M. (1992). High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and B-type chronic lymphocytic leukemia. Journal of Clinical Investigations, 89, 1690-1693.
41. Schmid, M. and Porzsolt, F. (1995). Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia. Leukemia and Lymphoma, 17, 401-410.
42. Semenzato, G., Trentin, L., Zambello, R., Agostini, C., Bulian, P., Siviero, F., Ambrosetti, A., Vinante, F., Prior, M., Chilosi, M. and Pizzolo, G. (1988). Origin of the soluble IL-2 receptor in the serum of patients with hairy cell leukemia. Leukemia, 2, 788-792.
43. Richards, J. M., Mick, R., Latta, J. M., Daly, K., Ratain, M. J., Vardiman, J. W. and Golomb, H. M. (1990). Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood, 76, 1941-1945.
44. Pizzolo, G., Ambrosetti, A., Vinante, F., Chilosi, M. and Semenzato, G. (1991). Serum interleukin-2 receptor as index of tumor burden in hairy cell leukemia. Blood, 77, 2540-2541.
45. Lauria, F., Rondelli, D., Raspadori, D., Zinzani, P. L., Benfenati, D., Pileri, S., Sabattini, E. and Tura, S. (1992). Serum soluble interleukin-2 receptor levels in hairy cell leukemia: Correlation with clinical and hematological parameters and with α-interferon treatment. Leukemia and Lymphoma, 7, 103-107.
46. Kluin-Nelemans, J. C. (1991). Hairy cell leukemia and its T-cell interactions. Leukemia and Lymphoma, 4, 159-166.
47. Chilosi, M., Semenzato, G., Cetto, G., Ambrosetti, A., Fiore-Donati, L., Perona, G., Berton, G., Lestani, M., Scarpa, A., Agostini, C., Trentin, L., Zambello, R., Masciarelli, M., Dazzi, F., Finante, F., Caligaris-Cappio, F. and Pizzolo, G. (1987). Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: Relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood, 70, 1530-1535.
48. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., Johnson, L., Alderson, M. R., Watson, J. D. and Giri, J. G. (1994). Cloning of a T-cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science, 264, 965-968.
49. Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S., Cosman, D. and Anderson, D. (1994). Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO Journal, 13, 2822-2830.
50. Raulet, D. H. (1989). The structure, function, and molecular genetics of the gamma/delta T-cell receptor. Annual Review of Immunology, 7, 175-207.
51. Moss, P. A. H., Rosenberg, W. M. C. and Bell, J. I. (1992). The human T-cell receptor in health and disease. Annual Review of Immunology, 10, 71-96.
52. Kluin-Nelemans, J. C., Kester, M. G. D., Melenhorst, J. J., Landegent, J. E., van de Corput, L., Willemze, R. and Falkenburg, J. H. F. (1996). Persistent clonal excess and skewed T-cell repertoire in T-cells from patients with hairy cell leukemia. Blood, 87, 3795-3802.
53. Wen, T., Mellstedt, H. and Jondal, M. (1990). Presence of clonal T-cell populations in chronic B-lymphocytic leukemia and smoldering myeloma. Journal of Experimental Medicine, 171, 659-666.
54. Farace, F., Orlanducci, F., Dietrich, P-Y., Gaudin, C., Angevin, E., Courtier, M-H., Bayle, C., Hercend, T. and Triebel, F. (1994). T-cell repertoire in patients with B chronic lymphocytic leukemia. Journal of Immunology, 153, 4281-4290.
55. + T-cell subsets in chronic lymphocytic leukemia. Journal of Immunology, 158, 1482-1489.
56. McCormack, J. E., Callahan, J. E., Kappler, J. and Marrack, P. C. (1993). Profound deletion of mature T-cells in vivo by chronic exposure to exogenous superantigen. Journal of Immunology, 150, 3785-3792.
57. Kluin-Nelemans, J. C., Kester, M. G. D., Corput van de, L., Boor, P. P. C., Landegent, J. E., Dongen van, J. J. M., Willemze, R. and Falkenburg, J. H. F. (1996). Restoration of abnormal T-cell receptor repertoire during interferon-alfa therapy in patients with hairy cell leukemia. Blood, 88 (suppl. 1):241a.
58. + T-lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles. Journal of Immunology, 153, 2479-2487.
59. Lanier, L. L., O'Fallon, S., Somoza, C., Philips, J. H., Linsley, P. S., Okumura, K., Ito, D. and Azuma, M. (1995). CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T-cell proliferation, cytokine production, and generation of CTL. Journal of Immunology, 154, 97-105.
60. Schwartz, R. H. (1993). T-cell anergy. Scientific American, 269, 48-54.
61. Dubey, C., Croft, M. and Swain, S. L. (1996). Naive and effector CD4 T-cells differ in their requirements for T-cell receptor versus costimulatory signals. Journal of Immunology, 157, 3280-3289.
62. Mondino, A. and Jenkins, M. K. (1994). Surface proteins involved in T-cell costimulation. Journal of Leukocyte Biology, 55, 805-815.
63. Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J. and Nadler, L. M. (1994). Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84, 3261-3282.
64. Staunton, D. E., Dustin, M. L. and Springer, T. A. (1989). Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature, 339, 61-64.
65. de Fougerolles, A. R., Stacker, S. A., Schwarting, R. and Springer, T. A. (1991). Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. Journal of Experimental Medicine, 174, 253-267.
66. de Fougerolles, A. R. and Springer, T. A. (1992). Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. Journal of Experimental Medicine, 175, 185-190.
67. Mackay, C. R. and Imhof, B. A. (1993). Cell adhesion in the immune system. Immunology Today, 14, 99-102.
68. + T-lymphocytes. Journal of Immunology, 148, 1985-1992.
69. van Seventer, G., Shimizu, Y., Horgan, K., Ginther Luce, G., Webb, D. and Shaw, S. (1991). Remote T-cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: Demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. European Journal of Immunology, 21, 1711-1718.
70. Inghirami, G., Wieczorek, R., Zhu, B-Y., Silber, R., Dalla-Favera, R. and Knowles, D. M. (1988). Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood, 72, 1431-1434.
71. Jansen, J. H., Harst van der, D., Wientjes, G. H. M., Kooy-Winkelaar, Y. M. C., Brand, A., Willemze, R. and Kluin-Nelemans, H. C. (1992). Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity. Blood, 80, 478-483.
72. Planken, E. V., Dijkstra, N. H., Bakkus, M., Willemze, R. and Kluin-Nelemans, J. C. (1996). Proliferation of precursor B-lineage acute lymphoblastic leukaemia by activating the CD40 antigen. British Journal of Haematology, 95, 319-326.
73. Ranheim, E. A. and Kipps, T. J. (1993). Activated T-cells induce expression of B7/BB1 on normal or leukemic B-cells through a CD40-dependent signal. Journal of Experimental Medicine, 177, 925-935.
74. Lane, P., Traunecker, A., Hubele, S., Inui, S., Lanzavecchia, A. and Gray, D. (1992). Activated human T-cells express a ligand for the human B-cell-associated antigen CD40 which participates in T-cell-dependent activation of B-lymphocytes. European Journal of Immunology, 22, 2573-2578.
75. Yellin, M. J., Sinning, J., Covey, L. R., Sherman, W., Lee, J. J., Glickman-Nir, E., Sippel, K. C., Rogers, J., Cleary, A. M., Parker, M., Chess, L and Lederman, S. (1994). T lymphocyte T-cell-B-cell-activating molecule/CD40-L molecules induce normal B-cells or chronic lymphocytic leukemia B-cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. Journal of Immunology, 53, 666-674.
76. Shamash, J., Davies, D. C., Rohatiner, A. Z. S., Young, B. D. and Lister, T. A. (1995). Induction of CD80 expression in low-grade B-cell lymphoma: a pôtential immunotherapeutic target. Leukemia, 9, 1349-1352.
77. Kluin-Nelemans, J. C., Beverstock, G. C., Mollevanger, P., Wessels, H. W., Hoogendoorn, E., Willemze, R. and Falkenburg, J. H. F. (1994). Proliferation and cytogenic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood, 84, 3134-3141.